Assessing Human Embryonic Stem Cell-Derived Dopaminergic Neuron Progenitor Transplants Using Non-invasive Imaging Techniques



Hill, Christopher ORCID: 0000-0003-3831-4569
(2020) Assessing Human Embryonic Stem Cell-Derived Dopaminergic Neuron Progenitor Transplants Using Non-invasive Imaging Techniques Molecular Imaging and Biology, 22 (5). pp. 1244-1254. ISSN 1095-0397, 1860-2002

[thumbnail of Mousavinejad_et_al_2020_accepted.pdf] Text
Mousavinejad_et_al_2020_accepted.pdf - Author Accepted Manuscript

Download (2MB) | Preview

Abstract

Purpose: Human pluripotent stem cell (hPSC)-derived dopaminergic neuron progenitor cells (DAPCs) are a potential therapy for Parkinson’s disease (PD). However, their intracranial administration raises safety concerns including uncontrolled proliferation, migration and inflammation. Here, we apply a bimodal imaging approach to investigate the fate of DAPC transplants in the rat striatum. Procedures: DAPCs co-expressing luciferase and ZsGreen or labelled with micron-sized particles of iron oxide (MPIOs) were transplanted in the striatum of RNU rats (n = 6 per group). DAPCs were tracked in vivo using bioluminescence and magnetic resonance (MR) imaging modalities. Results: Transgene silencing in differentiating DAPCs accompanied with signal attenuation due to animal growth rendered the bioluminescence undetectable by week 2 post intrastriatal transplantation. However, MR imaging of MPIO-labelled DAPCs showed that transplanted cells remained at the site of injection for over 120 days. Post-mortem histological analysis of DAPC transplants demonstrated that labelling with either luciferase/ZsGreen or MPIOs did not affect the ability of cells to differentiate into mature dopaminergic neurons. Importantly, labelled cells did not elicit increased glial reactivity compared to non-labelled cells. Conclusions: In summary, our findings support the transplantation of hPSC-derived DAPCs as a safe treatment for PD.

Item Type: Article
Uncontrolled Keywords: Dopaminergic neuron progenitor cells, Human pluripotent stem cell, Parkinson's disease, Non-invasive imaging, Bioluminescence, Magnetic resonance imaging
Depositing User: Symplectic Admin
Date Deposited: 07 May 2020 10:11
Last Modified: 01 Mar 2026 02:16
DOI: 10.1007/s11307-020-01499-4
Related Websites:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3086340
Disclaimer: The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.